Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koios Medical is a private healthcare AI company developing FDA-cleared and CE-marked clinical decision support software for ultrasound-based cancer diagnosis. Its core product family, Koios DS, uses artificial intelligence and machine learning to analyze ultrasound images and assist radiologists and technologists with breast and thyroid lesion assessment. The company positions its technology as a "Smart Ultrasound" platform that integrates into radiology workflows, including PACS and reporting systems, and aims to improve diagnostic accuracy while reducing unnecessary biopsies and follow-up procedures. Koios appears to operate as a commercial-stage software medical device company rather than a therapeutics developer, with a focus on imaging analytics and workflow support in oncology diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koios Medical.